Zealand Pharma appoints head of R&D as CEO
On Wednesday, Zealand Pharma has announced that Adam Steensberg, the company’s head of research and development, will become its new chief executive.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
As a part of a larger restructuring of the company, Zealand Pharma has announced on Wednesday that its executive vice president of research and development and chief medical officer, Adam Steensberg, will become its new chief executive office, according to a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma reports higher costs in 2021
For subscribers
.jpg&w=384&q=75)
